SOS1 and cancer: Taken together, these data suggest that SIAIS562055-induced degradation of SOS1 leads to the suppression of downstream signaling, which effectively inhibits the proliferation of KRAS-mutant cancer cells and shows synergistic effects when combined with KRAS inhibitors.